# US 2025/0095792 A1 · Method for identifying transformation products of antibiotics from known and potential unknown transformation pathways

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0095792 A1
- Document ID: US20250095792A1
- Status: Published application
- Kind: A1
- Application number: 18/735,796
- Filed: 2024-06-06
- Published: 2025-03-20
- Earliest claimed: 2023-09-05
- Applicants: Peking University; Nanyang Normal University
- Inventors: Weiling SUN; Jingrun HU; Yi LIU; Minjie DENG; Mingfei JI; Yuying LI
- Web page: https://patentgrep.com/patent/US20250095792A1

## CPC

- G16C 20/20: Identification of molecular entities, parts thereof or of chemical compositions
- G01N 30/7233: {interfaced to liquid or supercritical fluid chromatograph (interfaces in general for introducing or extracting samples to be analysed with specially adapted mass spectrometer, see H01J49/04)}
- G01N 30/8631: {Peaks}
- G01N 30/88: Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
- G01N 2001/4088: {filtration}
- G01N 2030/027: {Liquid chromatography}
- G01N 2030/884: {organic compounds}
- G16C: COMPUTATIONAL CHEMISTRY; CHEMOINFORMATICS; COMPUTATIONAL MATERIALS SCIENCE
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

A method for identifying transformation products of antibiotics from known and potential unknown transformation pathways includes: step 1: collecting samples, extracting antibiotics and transformation products thereof, and obtaining non-target data by ultra-high performance liquid chromatography-high resolution mass spectrometry; step 2: identifying transformation products of antibiotics from known and unknown transformation pathways; step 3: generating a list of candidate transformation products and annotating their structures; step 4: extracting feature fragments based on structure annotations of the transformation products obtained in step 3, and searching for spectra with the feature fragment, and supplementing the transformation products from unknown transformation pathway; and step 5: obtaining a final list of identified products based on annotated structures.

## Claims

### Claim 1

A method for identifying transformation products of antibiotics from known and potential unknown transformation pathways, comprising:
step 1: collecting samples from different sampling sites in a target area, extracting antibiotics and transformation products thereof, and collecting non-target data by ultra-high performance liquid chromatography-high resolution mass spectrometry to obtain a peak list;
step 2: based on the mass spectrometry data obtained in step 1, performing step A of identifying transformation products of the antibiotics from known transformation pathways and performing step B of identifying transformation products of the antibiotics from unknown transformation pathways;
wherein step A comprises: collecting structural information of known antibiotics, establishing an information list of parent antibiotics, and establishing a suspect list of transformation products; and step B comprises: establishing a molecular network, extracting all features of a sub-network where a parent is located, and obtaining the transformation products from the unknown transformation pathways;
step 3: obtaining a list of candidate transformation products based on the transformation products from the known and unknown transformation pathways obtained in step 2, and annotating structures of the transformation products;
step 4: extracting feature fragments based on structure annotations of the transformation products obtained in step 3, and searching for spectra with the feature fragments, and supplementing the transformation products from the unknown transformation pathways; and
step 5: obtaining a final list of identified products after annotating the structures of transformation products.

### Claim 2 (depends on 1)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 1, wherein:
step A comprises:
step A.1: collecting the structural information of the known antibiotics and establishing the information list of parent antibiotics;
step A.2: for a parent antibiotic obtained in step A.1, obtaining the suspect list of all transformation products; and
step A.3: merging the predicted transformation products obtained in step A.2.

### Claim 3 (depends on 2)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 2, wherein:
in step A.2, the suspect list of the transformation products established according to the known transformation pathways comprises known transformation products and predicted transformation products from the known transformation pathways.

### Claim 4 (depends on 2)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 2, wherein:
step A.3 comprises: removing a transformation product having a similarity of less than a set value and having the same molecular descriptor with a parent structure for merging the prediction results of the transformation products obtained in step A.2.

### Claim 5 (depends on 1)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 1, wherein:
step B specifically comprises:
step B.1: preprocessing the mass spectrometry data obtained in step 1 to obtain a feature quantification table and a mass spectrometry (MS)/MS spectral summary;
step B.2: establishing the molecular network with the feature quantification table and an MS/MS spectral summary obtained in step B.1; and
step B.3: extracting mass spectrum peak information of transformation products of the parent antibiotic from the unknown transformation pathways using the molecular network obtained in step B.2.

### Claim 6 (depends on 5)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 5, wherein:
step B.2 comprises: exporting the feature quantification table and the MS/MS spectral summary obtained in step B.1 to Global Natural Products Social Molecular Networking platform, creating the molecular network using a feature-based molecular networking workflow, and setting a minimum matched fragment ion and a cosine score.

### Claim 7 (depends on 6)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 6, wherein:
step B.3 comprises: in a graph of the molecular network established in step B.2, locating an area where the parent antibiotic and the known transformation products are present based on a mass-to-charge ratio of a precursor ion shown on a node in the molecular network, thereby extracting all the features of the sub-network, and obtaining mass spectra of the transformation products of the parent antibiotic from the unknown transformation pathways.

### Claim 8 (depends on 1)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 1, wherein:
step 3 comprises: annotating the structure of the transformation product from the unknown transformation pathways and assigning corresponding confidence levels 1 to 5 to the structures of all the transformation products.

### Claim 9 (depends on 1)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 1, wherein:
step 4 comprises: using fragment ions frequently occurring in the parent antibiotic and transformation products screened from the samples as the feature fragments, searching the peak list with the feature fragments, and supplementing the transformation product from the unknown transformation pathways.

### Claim 10 (depends on 8)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 8, wherein:
step 5 comprises: selecting the transformation products at the confidence levels 1 to 3 to obtain the final list of identified products.

### Claim 11 (depends on 3)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 3, wherein:
step A.3 comprises: removing a transformation product having a similarity of less than a set value and having the same molecular descriptor with a parent structure for merging the prediction results of the transformation products obtained in step A.2.

### Claim 12 (depends on 2)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 2, wherein:
step B specifically comprises:
step B.1: preprocessing the mass spectrometry data obtained in step 1 to obtain a feature quantification table and a mass spectrometry (MS)/MS spectral summary;
step B.2: establishing the molecular network with the feature quantification table and an MS/MS spectral summary obtained in step B.1; and
step B.3: extracting mass spectrum peak information of transformation products of the parent antibiotic from the unknown transformation pathways using the molecular network obtained in step B.2.

### Claim 13 (depends on 3)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 3, wherein:
step B specifically comprises:
step B.1: preprocessing the mass spectrometry data obtained in step 1 to obtain a feature quantification table and a mass spectrometry (MS)/MS spectral summary;
step B.2: establishing the molecular network with the feature quantification table and an MS/MS spectral summary obtained in step B.1; and
step B.3: extracting mass spectrum peak information of transformation products of the parent antibiotic from the unknown transformation pathways using the molecular network obtained in step B.2.

### Claim 14 (depends on 12)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 12, wherein:
step B.2 comprises: exporting the feature quantification table and the MS/MS spectral summary obtained in step B.1 to Global Natural Products Social Molecular Networking platform, creating the molecular network using a feature-based molecular networking workflow, and setting a minimum matched fragment ion and a cosine score.

### Claim 15 (depends on 13)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 13, wherein:
step B.2 comprises: exporting the feature quantification table and the MS/MS spectral summary obtained in step B.1 to Global Natural Products Social Molecular Networking platform, creating the molecular network using a feature-based molecular networking workflow, and setting a minimum matched fragment ion and a cosine score.

### Claim 16 (depends on 14)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 14, wherein:
step B.3 comprises: in a graph of the molecular network established in step B.2, locating an area where the parent antibiotic and the known transformation products are present based on a mass-to-charge ratio of a precursor ion shown on a node in the molecular network, thereby extracting all the features of the sub-network, and obtaining mass spectra of the transformation products of the parent antibiotic from the unknown transformation pathways.

### Claim 17 (depends on 2)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 2, wherein:
step 3 comprises: annotating the structure of the transformation product from the unknown transformation pathways and assigning corresponding confidence levels 1 to 5 to the structures of all the transformation products.

### Claim 18 (depends on 3)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 3, wherein:
step 3 comprises: annotating the structure of the transformation product from the unknown transformation pathways and assigning corresponding confidence levels 1 to 5 to the structures of all the transformation products.

### Claim 19 (depends on 2)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 2, wherein:
step 4 comprises: using fragment ions frequently occurring in the parent antibiotic and transformation products screened from the samples as the feature fragments, searching the peak list with the feature fragments, and supplementing the transformation product from the unknown transformation pathways.

### Claim 20 (depends on 3)

The method for identifying transformation products of antibiotics from known and potential unknown transformation pathways according to claim 3, wherein:
step 4 comprises: using fragment ions frequently occurring in the parent antibiotic and transformation products screened from the samples as the feature fragments, searching the peak list with the feature fragments, and supplementing the transformation product from the unknown transformation pathways.
